The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global microbial identification market size reached US$ 3.57 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.32 Billion by 2027, exhibiting a growth rate (CAGR) of 11.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Microbial identification refers to the process of identifying pathogens in mixed microbial communities by examining their behavior. It includes comparing a known and an unknown organism and eventually providing names to the analyzed species. It relies on various techniques, such as deoxyribonucleic acid (DNA) sequencing, riboprinter analysis, repeat-based polymerase chain reaction, and rapid pathogen confirmation. It delivers immediate and reliable results that help diagnose infectious diseases and the timely adoption of required medications and therapies. Besides this, it allows the detection of specific proteins, biochemical activities of the target cells, and gene sequences of microorganisms. As a result, microbial identification finds extensive applications in microbiological quality control at production facilities, academic research centers, and food processing units worldwide.
The rising prevalence of infectious diseases caused by microorganisms is increasing the need for microbial identification tests across the globe. The classification of microorganisms and microbes plays a vital role in disease analysis and providing appropriate treatment. In addition, the study of bacteria, parasites, fungi, and microbes is encouraging investors in the pharmaceutical industry to finance innovation in drug development. This represents another factor positively influencing the market. Apart from this, the increasing food safety concerns around the world are driving the need for microbial identification techniques to identify food spoilage contaminants. These techniques help retain the authenticity and flavor of processed food products and increase their shelf life. Furthermore, continuous advancements in the field of microbiology and microbial identification equipment are creating a positive market outlook. Moreover, various initiatives undertaken by governments of various countries to prevent the spread of infectious diseases, coupled with the increasing expenditure on the healthcare industry, are anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global microbial identification market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on products and services, technology, method and application.
Breakup by Products and Services:
Breakup by Technology:
Breakup by Method:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Biolog Inc., BioMerieux SA, Bruker Corporation, Charles River Laboratories International Inc., Eurofins Scientific SE, Liofilchem S.r.l, Merck KGaA, Shimadzu Corporation, Thermo Fisher Scientific Inc., VWR International LLC. (Avantor Inc.) and Wickham Micro Limited.
|Base Year of the Analysis||2021|
|Segment Coverage||Products and Services, Technology, Method, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Beckman Coulter Inc. (Danaher Corporation), Biolog Inc., BioMerieux SA, Bruker Corporation, Charles River Laboratories International Inc., Eurofins Scientific SE, Liofilchem S.r.l, Merck KGaA, Shimadzu Corporation, Thermo Fisher Scientific Inc., VWR International LLC. (Avantor Inc.) and Wickham Micro Limited.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at